Kim Papp, M.D., Ph.D., F.R.C.P.C.

Dr. Papp started his practice in dermatology 29 years ago and was a principle investigator in his first clinical study 27 years ago. Since that time, he has engaged in over 400 clinical studies ranging from Phase I through Phase IV, covering antibiotics, antivirals, vaccines, psoriatic arthritis, and of course dermatology related studies in acne, onychomycosis, rosacea, seborrhea, atopic dermatitis and psoriasis. Somewhat reflective of his contribution to the field of dermatology, he is one of the most frequently cited authors. He is also the founder and President of Probity Medical Research, Inc., a site management organization specializing in dermatology clinical trials. All the while, he remains committed to his practice and is increasingly vested in endeavors to streamline the conduct of clinical studies. He received his Doctor of Medicine degree from the University of Calgary Medical School and was a resident in Internal Medicine and Dermatology at the University of Toronto.